Combined hormonal contraception and its effects on mood: a critical review

European Journal of Contraception and Reproductive Health Care

Volumn 21, Issue 5, 2016, Pages 347-355

  Schaffir, Jonathan ^a   Worly, Brett L ^a   Gur, Tamar L ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

depression; Hormonal contraception; mood; side effects

Indexed keywords

DESOGESTREL; DROSPIRENONE; ESTROGEN; GESTAGEN; GESTODENE; LEVONORGESTREL; MEDROXYPROGESTERONE; NOMEGESTROL; NOMEGESTROL ACETATE; ORAL CONTRACEPTIVE AGENT; PROGESTERONE;

AFFECT; ANXIETY; DEPRESSION; FEMALE; HIGH RISK PREGNANCY; HORMONAL CONTRACEPTION; HUMAN; MENTAL INSTABILITY; MOOD; MOOD CHANGE; MOOD DISORDER; POSITIVE AND NEGATIVE AFFECT SCHEDULE; PREMENSTRUAL DYSPHORIC DISORDER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; CHEMICALLY INDUCED; PROTECTION; PSYCHOLOGY; RISK FACTOR;

AFFECT; CONTRACEPTIVES, ORAL, COMBINED; CONTRACEPTIVES, ORAL, HORMONAL; DEPRESSION; DEPRESSIVE DISORDER; FEMALE; HUMANS; PROGESTINS; PROTECTIVE FACTORS; RISK FACTORS;

EID: 84987973410     PISSN: 13625187     EISSN: 14730782     Source Type: Journal    
DOI: 10.1080/13625187.2016.1217327     Document Type: Review

References (63)

1. G.B.Slap. Oral contraceptives and depression:impact, prevalence and cause. J Adolesc Health Care. 1981;2:53–64.
2. S.A.Robinson, M.Dowell, D.Pedulla,. Do the emotional side-effects of hormonal contraceptives come from pharmacologic or psychological mechanisms? Med Hypotheses. 2004;63:268–273.
3. S.A.Sanders, C.A.Graham, J.L.Bass,. A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation. Contraception. 2001;64:51–58.
4. M.J.Rosenberg, M.S.Waugh Oral contraceptive discontinuation:a prospective evaluation of frequency and reasons. Am J Obstet Gynecol. 1998;179:577–582.
5. C.L.Westhoff, S.Heartwell, S.Edwards,. Oral contraceptive discontinuation:do side effects matter? Am J Obstet Gynecol. 2007;196:412.e1–e7.
6. C.A.Graham, R.Ramos, J.Bancroft,. The effects of steroidal contraceptives on the well-being and sexuality of women:a double-blind, placebo-controlled, two-centre study of combined and progestogen-only methods. Contraception. 1995;52:363–369.
7. K.M.Keyes, K.Cheslack-Postava, C.Westhoff,. Association of hormonal contraceptive use with reduced levels of depressive symptoms:a national study of sexually active women in the United States. Am J Epidemiol. 2013;178:1378–1388.
8. E.Toffol, O.Heikinheimo, P.Koponen,. Hormonal contraception and mental health:results of a population-based study. Hum Reprod. 2011;26:3085–3093.
9. E.Toffol, O.Heikinheimo, P.Koponen,. Further evidence for lack of negative associations between hormonal contraception and mental health. Contraception. 2012;86:470–480.
10. J.M.Duke, D.W.Sibbritt, A.F.Young Is there an association between the use of oral contraception and depressive symptoms in young Australian women? Contraception. 2007;75:27–31.
11. G.Svendal, M.Berk, J.A.Pasco,. The use of hormonal contraceptive agents and mood disorders in women. J Affect Disord. 2012;140:92–96.
12. B.J.Oddens. Women's satisfaction with birth control:a population survey of physical and psychological effects of oral contraceptives, intrauterine devices, condoms, natural family planning, and sterilization among 1466 women. Contraception. 1999;59:277–286.
13. K.A.Oinonen, D.Mazmanian Effects of oral contraceptives on daily self-ratings of positive and negative affect. J Psychosom Res. 2001;51:647–658.
14. A.B.Berenson, S.D.Odom, C.Radecki Breitkopf, M.Rahman. Physiologic and psychologic symptoms associated with use of injectable contraception and 20 microg oral contraceptive pills. Am J Obstet Gynecol. 2008;199:351.e1–e12.
15. A.Marriott, E.B.Faragher An assessment of psychological state associated with the menstrual cycle in users of oral contraception. J Psychosom Res. 1986;30:41–47.
16. V.Natale, P.Albertazzi Mood swings across the menstrual cycle:a comparison between oral contraceptive users and non-users. Biol Rhythm Res. 2006;37:489–495.
17. M.Almagor, Y.S.Ben-Porath Mood changes during the menstrual cycle and their relation to the use of oral contraceptive. J Psychosom Res. 1991;35:721–728.
18. J.Kulkarni, J.Liew, K.A.Garland. Depression associated with combined oral contraceptives – a pilot study. Aust Fam Physician. 2005;34:990.
19. Y.H.Wimberly, S.Cotton, A.M.Wanchick,. Attitudes and experiences with levonorgestrel 100 microg/ethinyl estradiol 20 microg among women during a 3-month trial. Contraception. 2002;65:403–406.
20. M.Akerlund, A.Rode, J.Westergaard. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol. Br J Obstet Gynaecol. 1993;100:832–838.
21. T.Greco, C.A.Graham, J.Bancroft,. The effects of oral contraceptives on androgen levels and their relevance to premenstrual mood and sexual interest:a comparison of two triphasic formulations containing norgestimate and either 35 or 25 microg of ethinyl estradiol. Contraception. 2007;76:8–17.
22. P.Warner, J.Bancroft Mood, sexuality, oral contraceptives and the menstrual cycle. J Psychosom Res. 1988;32:417–427.
23. J.Bancroft, D.Rennie The impact of oral contraceptives on the experience of perimenstrual mood, clumsiness, food craving and other symptoms. J Psychosom Res. 1993;37:195–202.
24. A.Walker, J.Bancroft Relationship between premenstrual symptoms and oral contraceptive use:a controlled study. Psychosom Med. 1990;52:86–96.
25. A.L.Coffee, T.J.Kuehl, S.Willis,. Oral contraceptives and premenstrual symptoms:comparison of a 21/7 and extended regimen. Am J Obstet Gynecol. 2006;195:1311–1319.
26. R.Sabatini, R.Cagiano Comparison profiles of cycle control, side effects and sexual satisfaction of three hormonal contraceptives. Contraception. 2006;74:220–223.
27. L.M.Lopez, D.A.Grimes, M.F.Gallo,. Skin patch and vaginal ring versus combined oral contraceptives for contraception. Cochrane Database Syst Rev. 2013;30:CD003552.
28. W.Urdl, D.Apter, A.Alperstein,. Contraceptive efficacy, compliance and beyond:factors related to satisfaction with once-weekly transdermal compared with oral contraception. Eur J Obstet Gynecol Reprod Biol. 2005;121:202–210.
29. G.S.Sucato, S.R.Land, P.J.Murray,. Adolescents' experiences using the contraceptive patch versus pills. J Pediatr Adolesc Gynecol. 2011;24:197–203.
30. M.D.Creinin, L.A.Meyn, L.Borgatta,. Multicenter comparison of the contraceptive ring and patch:a randomized controlled trial. Obstet Gynecol. 2008;111:267–277.
31. M.Shahnazi, A.F.Khalili, F.R.Kochaksaraei,. A comparison of second and third generations combined oral contraceptive pills effect on mood. Iran Red Crescent Med J. 2014;16:e13628.
32. J.B.Deijen, K.J.Duyn, W.A.Jansen, Use of a monophasic, low-dose oral contraceptive in relation to mental functioning. Contraception. 1992;46:359–367.
33. S.Kelly, E.Davies, S.Fearns,. Effects of oral contraceptives containing ethinylestradiol with either drospirenone or levonorgestrel on various parameters associated with well-being in healthy women:a randomized, single-blind, parallel-group, multicentre study. Clin Drug Investig. 2010;30:325–336.
34. M.Sangthawan, S.Taneepanichskul. A comparative study of monophasic oral contraceptives containing either drospirenone 3 mg or levonorgestrel 150 microg on premenstrual symptoms. Contraception. 2005;71:1–7.
35. J.Borenstein, H.-T.Yu, S.Wade,. Effect of an oral contraceptive containing ethinyl estradiol and drospirenone on premenstrual symptomatology and health-related quality of life. J Reprod Med. 2003;48:79–85.
36. V.Skrzypulec, A.Drosdzol. Evaluation of the quality of life and sexual functioning of women using a 30-microg ethinyloestradiol and 3-mg drospirenone combined oral contraceptive. Eur J Contracept Reprod Health Care. 2008;13:49–57.
37. Y.Zimmerman, J.-M.Foidart, A.Pintiaux,. Restoring testosterone levels by adding dehydroepiandrosterone to a drospirenone containing combined oral contraceptive:II. Clinical effects. Contraception. 2015;91:134–142.
38. H.Witjes, M.D.Creinin, I.Sundstrom-Poromaa,. Comparative analysis of the effects of nomegestrol acetate/17 β-estradiol and drospirenone/ethinylestradiol on premenstrual and menstrual symptoms and dysmenorrhea. Eur J Contracept Reprod Health Care. 2015;20:296–307.
39. J.Kristjansdottir, G.I.Olsson, C.Sundelin, Self-reported health in adolescent girls varies according to the season and its relation to medication and hormonal contraception – a descriptive study. Eur J Contracept Reprod Health. 2013;18:343–354.
40. M.A.Ott, M.L.Shew, S.Ofner,. The influence of hormonal contraception on mood and sexual interest among adolescents. Arch Sex Behav. 2008;37:605–613.
41. H.Joffe, L.S.Cohen, B.L.Harlow Impact of oral contraceptive pill use on premenstrual mood:predictors of improvement and deterioration. Am J Obstet Gynecol. 2003;189:1523–1530.
42. G.F.Trossarelli, G.Gennarelli, C.Benedetto,. Climacteric symptoms and control of the cycle in women aged 35 years or older taking an oral contraceptive with 0.150 mg desogestrel and 0.020 mg ethinylestradiol. Contraception. 1995;51:13–18.
43. N.Cinar, A.Harmanci, B.Demir, Effect of an oral contraceptive on emotional distress, anxiety and depression of women with polycystic ovary syndrome:a prospective study. Hum Reprod. 2012;27:1840–1845.
44. K.O’Connell, A.R.Davis, J.Kerns Oral contraceptives:side effects and depression in adolescent girls. Contraception 2007;75:299–304.
45. C.A.Graham, B.B.Sherwin A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive. J Psychosom Res. 1992;36:257–266.
46. A.L.Coffee, P.J.Sulak, T.J.Kuehl Long-term assessment of symptomatology and satisfaction of an extended oral contraceptive regimen. Contraception. 2007;75:444–449.
47. S.Nyberg Mood and physical symptoms improve in women with severe cyclical changes by taking an oral contraceptive containing 250 mcg norgestimate and 35 mcg ethinyl estradiol. Contraception. 2013;87:773–781.
48. E.R.Wiebe, L.A.Brotto, J.MacKay Characteristics of women who experience mood and sexual side effects with use of hormonal contraception. J Obstet Gynaecol Can. 2011;33:1234–1240.
49. M.Gingnell, J.Engman, A.Frick,. Oral contraceptive use changes brain activity and mood in women with previous negative affect on the pill – a double-blinded, placebo-controlled randomised trial of a levonorgestrel-containing combined oral contraceptive. Psychoneuroendocrinology. 2013;38:1133–1144.
50. A.Borgstrom, K.Kask, M.Gulinello,. Patients with adverse mood effects from combined oral contraceptives have lower levels of prepulse inhibition than healthy controls. Psychoneuroendocrinology. 2008;33:487–496.
51. A.J.Rapkin, M.Morgan, C.Sogliano,. Decreased neuroactive steroids induced by combined oral contraceptive pills are not associated with mood changes. Fertil Steril. 2006;85:1371–1378.
52. B.Segebladh, A.Borgstrom, V.Odlind,. Prevalence of psychiatric disorders and premenstrual dysphoric symptoms in patients with experience of adverse mood during treatment with combined oral contraceptives. Contraception. 2009;79:50–55.
53. A.Borgstrom, V.Odlind, L.Ekselius, Adverse mood effects of combined oral contraceptives in relation to personality traits. Eur J Obstet Gynecol Reprod Biol. 2008;141:127–130.
54. K.Stidham Hall, K.O’Connell White, V.I.Rickert,. Influence of depressed mood and psychological stress symptoms on perceived oral contraceptive side effects and discontinuation in young minority women. Contraception. 2012;86:518–525.
55. E.A.Young, S.G.Kornstein, A.T.Harvey,. Influences of hormone-based contraception on depressive symptoms in premenopausal women with major depression. Psychoneuroendocrinology. 2007;32:843–853.
56. U.Ernst, L.Baumgartner, U.Bauer, Improvement of quality of life in women using a low-dose desogestrel-containing contraceptive:results of an observational clinical evaluation. Eur J Contracept Reprod Health Care. 2002;7:238–244.
57. J.C.Huber, M.S.Heskamp, G.A.K.Schramm. Effect of an oral contraceptive with chlormadinone acetate on depressive mood:analysis of data from four observational studies. Clin Drug Investig. 2008;28:783–791.
58. K.Cheslack-Postava, K.M.Keyes, S.R.Lowe, Oral contraceptive use and psychiatric disorders in a nationally representative sample of women. Arch Womens Ment Health. 2015;18:103–111.
59. J.Francis, L.Presser, K.Malbon,. An exploratory analysis of contraceptive method choice and symptoms of depression in adolescent females initiating prescription contraception. Contraception. 2015;91:336–343.
60. S.Garbers, N.Correa, N.Tobier,. Association between symptoms of depression and contraceptive method choices among low-income women at urban reproductive health centers. Matern Child Health J. 2010;14:102–109.
61. K.S.Kendler, N.G.Martin, A.C.Heath,. A twin study of the psychiatric side effects of oral contraceptives. J Nerv Ment Dis. 1988;176:153–160.
62. K.A.Oinonen Putting a finger on potential predictors of oral contraceptive side effects:2D:4D and middle-phalangeal hair. Psychoneuroendocrinology. 2009;34:713–726.
63. E.Elaut, A.Buysse, P.De Sutter,. Relation of androgen receptor sensitivity and mood to sexual desire in hormonal contraception users. Contraception. 2012;85:470–479.